555 POSTER The PARP inhibitor, ABT-888 overcomes resistance in temozolomide refractory breast and prostate xenograft tumors implanted in metastatic sites in vivo
Autor: | Palma, J., Rodriguez, L., Wang, Y.W., Bukofzer, G., Hickson, J., Penning, T., Giranda, V., Rosenberg, S., Frost, D., Donawho, C. |
---|---|
Zdroj: | In EJC Supplements 2008 6(12):175-175 |
Databáze: | ScienceDirect |
Externí odkaz: |